Literature DB >> 22314828

Effects of inorganic arsenic on bone marrow hematopoietic cells: an emphasis on apoptosis and Sca-1/c-Kit positive population.

Jacintha Archana Pereira1, Prosun Das, Malay Chaklader, Sumanta Chatterjee, Pratima Basak, Samaresh Chaudhuri, Sujata Law.   

Abstract

Apoptosis, proliferation and differentiation are balanced molecular processes which may alter their pattern during environmental insults. Arsenic is an environmental pollutant, ranks 20(th) in abundance in the earth crust, 14(th) in sea water and 12(th) in the human body. Millions of people worldwide are chronically exposed to arsenic often due to naturally occurring arsenic in ground water. Hematopoietic stem cells within the bone marrow are the source of all haematopoietic cell lineages and are essential for tissue development throughout the life. In this experimental study, we have evaluated the impact of arsenic, on blood and blood forming cells by the changes in their cellular morphology, immune functional capacity, alteration of bone marrow CD34 positive stem/progenitors and changes in the phenotype of Sca-1, c-Kit dual positive primitive stem cell population. The study revealed that arsenic has a significant effect on bone marrow and hematopoietic stem cells, their immune capacity and upregulation of death process, all indicative of impairment in differentiation suggesting presence of deregulation in their precursors by arsenic toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22314828     DOI: jsc.2010.5.3.117

Source DB:  PubMed          Journal:  J Stem Cells        ISSN: 1556-8539


  2 in total

Review 1.  Lead, Arsenic, and Manganese Metal Mixture Exposures: Focus on Biomarkers of Effect.

Authors:  V M Andrade; M L Mateus; M C Batoréu; M Aschner; A P Marreilha dos Santos
Journal:  Biol Trace Elem Res       Date:  2015-02-20       Impact factor: 3.738

2.  The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone.

Authors:  Cong Liu; Anzhi Hu; Huijuan Chen; Jing Liang; Mancang Gu; Yang Xiong; Chao-Feng Mu
Journal:  Acta Pharm Sin B       Date:  2021-06-21       Impact factor: 11.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.